The rights under the deposited shares can be exercised by the GDR holders only through the GDR Depositary and individual GDR holders do not have any direct right to either attend the shareholders’ meeting or to exercise any voting rights under the deposited shares. The GDR holders have the right to convert their GDRs into shares. (ii) The Bank of New York Mellon holds shares in its capacity as the depositary (the GDR Depositary) for the GDR holders and is not the beneficial owner of such shares. In reliance on this obligation vested in the holders of major holdings, the Bank postulates that no other entities nor any natural persons hold directly and/or indirectly ten or more percent of the Bank's shares. The table provides all self-declared major holders whose notifications have been received. Information on major holdings is based on self-declarations by individual holders pursuant to the applicable provisions of the Slovenian legislation, which require that the holders of shares in a listed company notify the company whenever their direct and/or indirect holdings go over the present thresholds of 5%, 10%, 15%, 20%, 25%, 1/3, 50% or 75%. (i) Information is sourced from the NLB shareholders book available at the web services of CSD (Central Security Depository, Slovenian: KDD - Centralna klirinško depotna družba) to the CSD members. of which European Bank for Reconstruction and Development (EBRD) and Schroders Plc(iii),(iv).Shareholderīank of New York Mellon on behalf of the GDR holders (ii) The following table represents NLB's main shareholders as of 30 September 2023 (i). The shares are listed on Prime Market of Ljubljana Stock Exchange (ISIN SI0021117344, Ljubljana Stock Exchange trading symbol: NLBR) and the global depositary receipts (GDR), representing shares, are listed on the Main Market of London Stock Exchange (ISIN: US66980N2036 and US66980N1046, London Stock Exchange GDR trading symbol: NLB and 55VX). NLB's issued share capital is divided into 20,000,000 shares. The Novo Nordisk logo is the Apis bull, one of the sacred animals of ancient Egypt.Ownership structure of Nova Ljubljanska banka d.d., Ljubljana (NLB) The corporation was created in 1989, through a merger of two Danish companies which date back to the 1920s. Novo Nordisk employs more than 48,000 people globally, and markets its products in 168 countries. The company makes several drugs under various brand names, including Levemir, Tresiba, NovoLog, Novolin R, NovoSeven, NovoEight, and Victoza. Novo Nordisk is also involved with hemostasis management, growth hormone therapy, and hormone replacement therapy. Its main product is the drug semaglutide, used to treat diabetes under the brand name Ozempic and obesity under the brand name Wegovy. Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes care medications and devices. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority of its voting shares. Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.

Nova stock price